These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 27918539)

  • 1. Rapidly evolving homing CRISPR barcodes.
    Kalhor R; Mali P; Church GM
    Nat Methods; 2017 Feb; 14(2):195-200. PubMed ID: 27918539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
    Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
    Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas-Mediated Knockin in Human Pluripotent Stem Cells.
    Verma N; Zhu Z; Huangfu D
    Methods Mol Biol; 2017; 1513():119-140. PubMed ID: 27807834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of the CRISPR system in applications in genome manipulation.
    Lau V; Davie JR
    Biochem Cell Biol; 2017 Apr; 95(2):203-210. PubMed ID: 28103055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
    Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
    Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells.
    Gong H; Liu M; Klomp J; Merrill BJ; Rehman J; Malik AB
    Sci Rep; 2017 Feb; 7():42127. PubMed ID: 28198371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
    Gebler C; Lohoff T; Paszkowski-Rogacz M; Mircetic J; Chakraborty D; Camgoz A; Hamann MV; Theis M; Thiede C; Buchholz F
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27576906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
    Zheng W
    Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving CRISPR-Cas9 On-Target Specificity.
    Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Rehman K
    Curr Issues Mol Biol; 2018; 26():65-80. PubMed ID: 28879857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-CAS9 D10A nickase target-specific fluorescent labeling of double strand DNA for whole genome mapping and structural variation analysis.
    McCaffrey J; Sibert J; Zhang B; Zhang Y; Hu W; Riethman H; Xiao M
    Nucleic Acids Res; 2016 Jan; 44(2):e11. PubMed ID: 26481349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes.
    Oliveros JC; Franch M; Tabas-Madrid D; San-León D; Montoliu L; Cubas P; Pazos F
    Nucleic Acids Res; 2016 Jul; 44(W1):W267-71. PubMed ID: 27166368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 editing of the genome for cancer modeling.
    Guernet A; Grumolato L
    Methods; 2017 May; 121-122():130-137. PubMed ID: 28288827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.